KEDRION S.p.A.

ALBU-K

Pharmaceutical preparations in the nature of albumin-derived products for the treatment of medical conditions such as shock and blood loss due to trauma, burns, and surgery;

ALBUKED

Albumin-derived pharmaceutical preparations for the treatment of shock and blood loss due to trauma, burns, and surgery;

GAMMA-K

Pharmaceutical preparations in the nature of gamma globulin-derived products for treating a variety of infectious and inflammatory diseases and autoimmune disorders;

GAMMAKED

Gamma globulin-derived pharmaceutical preparations for treating a variety of infections and inflammatory diseases and autoimmune disorders;

KEDRION

Scientific and clinical research services and industrial research in the field of biological and biotechnological pharmaceutical products;

KEDRION

Chemical pharmaceutical preparations, namely, laxatives, vitamins, antithrombotic agents, antimicrobials for dermatologic use; antiseptics; antibacterial pharmaceuticals for systemic purposes, pharmaceutical immunostimulants, analgesics, ophthalmological preparations, nutritional supplements; biological blood derivates, namely, plasma proteins, and antibacterial and antiviral vaccines derived naturally or from biotechnology;Business management of therapeutical centers, in particular plasma collection centers and blood banks;Medical services, namely, providing advice, management and counseling in medical matters; medical services, namely, disease management programs;